Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.44 +0.64 (+3.23%)
At close: Oct 20, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Total Current Liabilities (2010 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) posted Total Current Liabilities of $361.44 million for Q2 2026, up 9.5% from $330.02 million a year earlier and up 18.3% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Acadia Pharmaceuticals' Total Current Liabilities came in at $277.11 million, down 29.8% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 21.2% (FY2020 to FY2025).
  • In prior years, Acadia Pharmaceuticals' Total Current Liabilities was $394.87 million in FY2024 (+55.3%), $254.25 million in FY2023 (+102.4%), $125.63 million in FY2022 (+30.8%) and $96.07 million in FY2021 (-9.3%).
  • The Q2 2026 figure stands as the highest quarterly Total Current Liabilities since Q4 2024.
  • On a year-over-year basis, Total Current Liabilities increased in five of the last eight quarters, with growth averaging 11.6%.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q4 2023, with growth of 102.4%; the weakest was Q4 2025, with a decline of 29.8%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $305.52 million (Q1 2026), $277.11 million (Q4 2025) and $356.58 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 54.90 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 41.64 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 31.55 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 11.02 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 32.65 Bn
10 Acadia Pharmaceuticals 3.51 Bn 36.36 Mn 279.64 Mn 361.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 361.44 Mn
Mar 31, 2026 305.52 Mn
Dec 31, 2025 277.11 Mn
Sep 30, 2025 356.58 Mn
Jun 30, 2025 330.02 Mn
Mar 31, 2025 302.53 Mn
Dec 31, 2024 394.87 Mn
Sep 30, 2024 343.95 Mn
Jun 30, 2024 337.85 Mn
Mar 31, 2024 330.60 Mn
Dec 31, 2023 254.25 Mn
Sep 30, 2023 209.60 Mn
Jun 30, 2023 187.94 Mn
Mar 31, 2023 224.30 Mn
Dec 31, 2022 125.63 Mn
Sep 30, 2022 116.57 Mn
Jun 30, 2022 117.68 Mn
Mar 31, 2022 119.60 Mn
Dec 31, 2021 96.07 Mn
Sep 30, 2021 88.22 Mn
API Access

Acadia Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ACAD&period=max&api_key=YOUR_API_KEY